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From the statistical learning perspective, this paper shows a new direction for the use of growth 
mixture modeling (GMM), a method of identifying latent subpopulations that manifest 
heterogeneous outcome trajectories. In the proposed approach, we utilize the benefits of the 
conventional use of GMM for the purpose of generating potential candidate models based on 
empirical model fitting, which can be viewed as unsupervised learning. We then evaluate 
candidate GMM models on the basis of a direct measure of success; how well the trajectory types 
are predicted by clinically and demographically relevant baseline features, which can be viewed as 
supervised learning. We examine the proposed approach focusing on a particular utility of latent 
trajectory classes, as outcomes that can be used as valid prediction targets in clinical prognostic 
models. Our approach is illustrated using data from the Longitudinal Assessment of Manic 
Symptoms (LAMS) study.
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The use of growth mixture modeling (GMM) [1–3] has been growing in various fields [4–
15] as a flexible way of identifying latent subpopulations that manifest heterogeneous 
outcome trajectories. The main interest in GMM has been meaningful interpretation of 
longitudinal heterogeneity in the target population. Naturally, recovering true models 
became a central issue as different versions of trajectory class solutions will lead to different 
interpretations and potentially different policy and clinical implications.
As in any exploratory modeling involving latent classes, identification of trajectory classes 
can be affected by various factors such as sample size, parametric assumptions, model 
specification, and presence or absence of auxiliary variables such as predictors, concurrent 
outcomes, and distal outcomes of the trajectory classes [16–22]. As we try to identify 
trajectory classes considering the aforementioned components, complexities and variations 
in model specifications quickly increase along with computational difficulties. In the field of 
machine learning, this type of modeling strategy is categorized as unsupervised learning, 
which is generally considered a challenging task given the lack of direct measures of success 
[23–24].
In contrast, identifying models that perform well in terms of targeted utilities is a relatively 
straightforward task. In the field of machine learning, this type of modeling strategy is 
categorized as supervised learning, where the candidate models are evaluated in terms of 
direct measures of success such as prediction or classification accuracy. Shifting our focus 
from recovery of true models to specific utilities opens up new possibilities in terms of how 
we evaluate GMM models and how the GMM results can be used in clinical research and 
practice. Whereas recovering true models and interpreting them is important in improving 
our understanding of the population heterogeneity, being able to accurately predict or 
classify individual level outcomes is important in improving the quality in personalized 
treatment and intervention. This may seem like a subtle difference, although it makes 
considerable differences in terms of how candidate models are evaluated and utilized. We 
intend to examine these new possibilities focusing on a specific utility of GMM as a way of 
producing valid prediction targets. In this context, identifying models that capture individual 
heterogeneity without overfitting is the goal of model selection, which is consistent with the 
goal of model selection in supervised learning.
Specifically, we utilize the benefits of the conventional use of GMM for the purpose of 
generating potential candidate models based on empirical model fitting, which can be 
viewed as unsupervised learning. We then propose to evaluate candidate GMM models on 
the basis of a direct measure of success; how well they are predicted by clinically and 
demographically relevant baseline features (antecedent validators), which can be viewed as 
supervised learning. Establishing the validity of prediction targets is a challenging, but 
critical process to ensure that they are worthy of predicting and clinically meaningful. 
Assessing the validity of latent trajectory classes based on their relationships with other 
variables is not new [19, 22]. Latent trajectory classes may have various roles, for example, 
as an outcome, as a predictor of future outcomes, or as a key component in complex 
theoretical models. Embedding these features in GMM may support the validity of the 
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trajectory class solutions and lead to fuller interpretation of longitudinal heterogeneity in the 
target population. However, the main interest still has been in interpretation and therefore 
little attention has been given to the possibility of utilizing these features to directly evaluate 
the performance of GMM solutions at the individual level.
2 Motivating Example: The LAMS Study
The LAMS study [6, 25, 26] was designed to investigate phenomenology, development of 
bipolar disorder and related conditions, and to establish predictors of functional outcomes in 
children with elevated manic symptoms. Children aged 6 to 12 years at screening and their 
parents were recruited from nine outpatient clinics associated with four university affiliated 
LAMS sites. A primary outcome in the LAMS study is symptoms of mania as measured by 
the Parent General Behavior Inventory 10-item Mania Form (PGBI-10M) [27]. Parents 
completed the PGBI-10M at five assessments during the two-year period (at baseline, 6, 12, 
18, and 24 months). Among 707 children enrolled in the study, we included 682 cases in our 
analyses, excluding ineligible cases and four cases with missing outcome information at all 
assessment points. Table 1 shows sample statistics of the PGBI-10M outcome and a small 
set of baseline variables used in our analyses.
Whether there are heterogeneous trajectory types of manic symptoms is a primary question 
in the LAMS study [6]. As in most GMM applications, identifying true trajectory classes is 
expected to be challenging as it can be affected by various factors such as sample size, 
model specification, and auxiliary information. Further, various practical questions arise 
surrounding the manic symptom trajectory class membership, such as whether we can 
predict the trajectory type early on (e.g., using baseline characteristics), whether the 
trajectory type is associated with relevant concurrent outcomes (e.g., depression, bipolar 
diagnosis), and whether we can predict distal outcomes (e.g., future delinquent behaviors) 
using the PGBI-10M trajectory type. As we try to identify true trajectory classes and also 
answer these questions, complexities and variations in model specifications quickly increase 
along with computational difficulties.
Evaluating and utilizing numerous trajectory class solutions is a challenging issue when our 
goal is interpretation of the population heterogeneity. However, when the goal is simpler and 
specific, such as predicting or classifying individual outcomes, how we select and use GMM 
solutions also becomes a simpler problem. One of the key interests in LAMS is in 
establishing prognostic models that accurately predict the type of manic symptom course 
early on. Ultimately, these models are intended for the use in clinical practice to improve 
personalized treatment based on early prediction. Separating out a large proportion of 
children who would remain non-problematic is especially critical as it is the first step 
towards efficient clinical practice. If we can separate them out early on, clinicians will be 
able to treat individuals in the elevated risk trajectory classes with confidence, having ruled 
out those in the low risk trajectory class who may experience iatrogenic adverse effects from 
antimanic treatments. In this context, we can narrow the goal of GMM to formulating valid 
prediction targets with a specific contrast of trajectory classes (low risk vs. the rest). With 
this simple classification structure, validating the formulated prediction targets in terms of 
their relationship with relevant baseline, concurrent, or distal measures becomes a feasible 
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task. In particular, we will focus on assessing the quality of prediction by clinically and 
demographically relevant baseline characteristics (antecedent validators) given our interest 
in using trajectory types as outcomes.
3 Unsupervised Learning with GMM
Growth mixture modeling (GMM) is a flexible method of identifying latent subpopulations 
that manifest heterogeneous trajectory patterns [1–3]. For example, according to our 
previous investigation [6], qualitatively different patterns of manic symptom expression are 
apparent in LAMS over the two-year course of observation. In this situation, standard mixed 
effects modeling is unlikely to capture the longitudinal heterogeneity sufficiently well, 
necessitating consideration of multiple trajectory classes. GMM has been gaining popularity 
especially with accessible latent variable modeling software such as Mplus [28].
The resulting trajectory types from GMM may provide insights and useful summary 
information that cannot be directly obtained from observed data. Despite its potential 
utilities, GMM has been mostly used as an exploratory tool to generate theories, at least 
partly due to uncertainties surrounding model evaluation and selection. Identification of 
trajectory classes can be affected by various factors such as model specification and 
auxiliary information. As we explore various combinations of these components, we can 
easily end up with abundance of candidate models. With such variations and possible 
complexities, identifying and using latent classes is generally considered a challenging task. 
In machine learning, this type of exploratory modeling strategy is categorized as 
unsupervised learning given the lack of direct measures of success [23–24].
The same exploratory nature also makes GMM a convenient and effective tool that facilitates 
discovery of latent trajectory types. Using clinical thresholds would be a more conventional 
way of classification, although the strategy can be arbitrary and inefficient when classifying 
individuals based on repeated measures, in particular with substantial missing data. In 
LAMS, about half of the study sample have missing manic symptom data at one or more 
assessment points. GMM utilizes all available data and empirical model fitting, and 
therefore considerable gain in reliability and efficiency is expected. This is not a trivial 
advantage as it is directly related to better prediction quality. Statistically identified 
trajectory classes from GMM can readily serve as classification categories, which is another 
convenient feature we will utilize in formulating prediction targets.
Here we briefly describe the GMM procedures we used for the purpose of discovery of 
latent trajectory class solutions (unsupervised learning). To focus on illustrating the 
proposed approach using the LAMS data, we limited the range of possible models that will 
be validated in terms of the prediction quality (supervised learning). We used a simple 
quadratic growth specification with restricted variance/covariance structures. However, 
various alternative model specifications are possible, which will lead to a much wider array 
of GMM solutions. With our limited setting, we obtained 43 models that reached normal 
convergence using the LAMS data.
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3.1 GMM without Covariates
We first conducted GMM without adjusting for any baseline covariates. The outcome Y 
(PGBI-10M) for individual i (i = 1, 2, …, N) at time point t (t = 1, 2, …, T) conditioned on 





where there are J possible trajectory classes (j = 1, 2, …, J). In line with LAMS, a quadratic 
growth model was chosen to capture potentially nonlinear patterns across five assessments 
(baseline, 6, 12, 18, and 24 month). This model includes three mean growth parameters: the 
initial status (η1j), linear growth (η2j), and quadratic growth (η3j) for trajectory class j. The 
time score St reflects linear and  quadratic growth. The measurement errors εij = (εij1, ⋯, 
εijT) are assumed to be normally distributed with εij ~ MN(0, Σε), where the associated 
variances are allowed to vary over time. The random effects (ζ1ij, ζ2ij, ζ3ij) associated with 
growth parameters are also assumed to be normally distributed as MN(0, Σζ). To maintain 
identifiability in models with larger numbers of classes, we imposed restrictions that Σε is 
diagonal and that Σε and Σζ do not vary across trajectory classes. We used four variations of 
Σζ: models allowing for all three random effects, models allowing for random linear slope/
intercept (Var(ζ3i) = 0), models allowing for random intercept only (Var(ζ2i) = Var(ζ3i) = 0), 
and models with no random effects (Var(ζ1i) = Var(ζ2i) = Var(ζ3i) = 0).
The probability of subject i belonging to a certain trajectory class j (πij = Pr(Ci = j)) is 
expressed in terms of a multinomial logit model,
(3.5)
for j = 1, 2, …, (J − 1), where logit(πij) = log(πij/πiJ).
3.2 GMM with Covariates
We also conducted GMM with baseline covariates as predictors of the trajectory class 
membership and as predictors of the growth parameters. The outcome Y (PGBI-10M) for 
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where the relationship between the three growth factors and the vector of covariates X is 
captured by the vectors of regression coefficients λ1, λ2, and λ3. These regression 
coefficients, in principle, can vary across trajectory classes (j = 1, 2, …, J). We imposed the 
equality restrictions on these parameters to avoid serious convergence problems and to 
maintain identifiability in models with larger numbers of classes. However, in principle, one 
may choose to consider both sets of models with and without these restrictions.
The probability of subject i belonging to a certain trajectory class (πij = Pr(Ci = j)) depends 
on the influence of covariates, and this association can vary by trajectory class. The 
multinomial logit model of πij conditioned on covariates subsumed in vector Xi is described 
as
(3.10)
for j = 1, 2, …, (J − 1), where β1j is a vector of multinomial logit regression coefficients with 
dimension the same as the length of Xi. In the LAMS application, we used the same set of 
baseline covariates (age, sex, Medicaid and CDRS-R) as the predictors of the growth 
parameters and the trajectory class membership.
Based on the model specifications described above, we conducted a series of GMM with 
varying numbers of classes. We calculated maximum likelihood (ML) estimates using the 
expectation maximization (EM) algorithm [29–32] implemented in the Mplus program [28]. 
Within each type of Σζ restrictions, we increased the number of classes until the covariance 
matrices Σε and Σζ in any of the classes was not positive definite, any of the classes has less 
than ten individuals (using the most likely class membership), or the model could not be 
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identified. We used ample starting values to avoid potential convergence at local maxima 
(3000 for the initial and 300 for the final stage optimization in Mplus).
From (3.6)–(3.10), the log-likelihood for the observed data {Yi : i = 1, ⋯, N} is
(3.11)
where ηj = (η1j, η2j, η3j), λ = (λ1, λ2, λ3),  for i = 1, ⋯, N, and πij(β) = 
Pr(Ci = j|Xi, β01, β11, ⋯, β0J, β1J) denotes the likelihood that Yi arising from mixture 
component j given Xi.
The log-likelihood of the complete-data (Yi, Ci : i = 1 ⋯, N) can be written as
(3.12)
To maximize (3.11), the E step computes the expected values of the log-likelihood in (3.12) 
given observed data and the current parameter estimates (β*, η*, λ*, ). Latent 
trajectory class C is considered as missing data in this step. That is, the E step computes
(3.13)
where  is the posterior class probability of subject i belonging to 
class j conditioned on (Yi, Xi, β*, , λ*, ) calculated as
(3.14)
The M step computes the parameter estimates that maximize the quantity obtained from the 
E step. This procedure continues until it reaches the optimal status.
We monitored Bayesian information criteria (BIC; [33]) and conducted bootstrapped 
likelihood ratio test (BLRT; [34]). Using BIC or BLRT has been examined as a preferred 
method of model selection in GMM [21, 35]. Within each type of Σζ restrictions, best fitting 
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models were identified based on BIC and BLRT. In this study, we report BIC and BLRT 
results, although we do not use them for model evaluation and selection.
3.3 Formulating Practical Prediction Targets
In this paper, we focus on a specific utility of GMM as a way of constructing prediction 
targets based on empirical model fitting. Ultimately, these GMM-based prediction targets are 
intended for the use as reliable and valid outcomes in clinical prognostic models. Classifying 
patients is common in clinical practice and research, often implemented by applying fixed 
clinical thresholds. This is necessary and practical even when the outcome is dimensional as 
most treatment, prevention, and intervention decisions are made in a categorical manner 
(e.g., surgery or not, prescription or not). In this context, GMM has a great potential as a tool 
for patient classification. To improve the practicality of GMM-based classification, we 
propose to formulate prediction targets with a specific contrast of trajectory classes. This is 
an important consideration as building prognostic models with good predictive power and 
validating them is likely more challenging when aiming to classify patients into multiple 
categories. Further, using prediction targets with fewer categories makes the prognostic 
models easier to understand and use in clinical practice.
In LAMS, separating out low risk children is of great clinical importance. We visually 
inspected all candidate GMM models to examine if this clinical intention can be aligned 
with the results of empirical clustering. All GMM models, with and without covariates, 
consistently exhibited trajectory classes that start with the PGBI-10M score of around 12 or 
lower and then gradually decrease. From the clinical perspective, these classes are clearly 
the least problematic. This interpretation is also supported by a previously suggested clinical 
threshold that sets PGBI-10M ≥ 12 as elevated in manic symptoms [25–27]. One way to 
categorize trajectory classes would be to use a fixed threshold (e.g., PGBI-10M < 12), which 
will provide validation results more in line with those from the conventional method of using 
observed measures. In this study, we instead categorize only the bottom class with the lowest 
mean trajectory as low risk. This approach allows the level of PGBI-10M to vary across 
different GMM models, and therefore will inform us how the prediction quality varies 
depending on how conservatively individuals are classified as low risk. Identifying the 
bottom trajectory class was straightforward in the LAMS example as all GMM models had a 
trajectory class that has the lowest estimated mean PGBI-10M across all five assessments. In 
different applications, different rules may need to be formulated depending on the clinical 
purpose of classification.
Let us designate the Jth class as the lowest risk trajectory class in each GMM model with J 
classes. From (3.14), the posterior probability of belonging to the low risk class (class J) for 
person i is p̂iJ, which denotes piJ evaluated at the maximum likelihood estimates of model 
parameters (β, η, λ, Σζ, Σε). The posterior probability of belonging to the elevated risk 
category is simply calculated as .
Then, in each GMM model, we can define the risk status of individual i as
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It is a common practice to ignore uncertainties when classifying individuals based on 
observed measures. Similarly, when using GMM, we can classify individuals into the most 
likely category based on their posterior class probabilities as is done in (3.15). Another way 
of utilizing posterior class probabilities is to create multiple versions of Li via multiple 
independent pseudoclass draws [37–38], which makes it possible to reflect uncertainties in 
classification. That is, in each GMM model, using the posterior class probability of 
belonging to the low risk trajectory class (p̂iJ), the risk status of individual i in the rth 
pseudoclass draw is defined as
(3.16)
where u(r) denotes the realization of drawing a random sample from a uniform (0, 1) 
distribution for r = 1, 2, 3, …, R, and R is the total number of psudoclass draws. We used 20 
draws in the LAMS application, resulting in 20 versions of Li for person i based on each 
GMM model. For each GMM model, the quality of each version of the prediction target 
(i.e., ) is assessed, and the overall quality of the prediction is obtained by 
averaging the results across multiple versions of pseudoclass draws.
4 Supervised Learning for Validation
The validity of GMM-based prediction targets is supported by the use of empirically derived 
trajectory classes and clinical insights. However, this initial validation process, embedded in 
formulation of prediction targets, may not necessarily narrow the range of prediction targets. 
Additional validation efforts will further support the validity of formulated prediction targets 
and help narrow our choice. One popular way of model selection in GMM is to assess the 
model fit, which significantly reduces the number of candidate models. For example, 11 
models are selected by BIC and/or BLRT in the LAMS application. However, it is unclear 
whether this approach is ideal when we intend to use trajectory classes as outcomes to be 
predicted at the individual level. Further, the formulated prediction targets (e.g., 2 types in 
LAMS: low and elevated risk trajectory types) are not necessarily the same as the GMM-
generated trajectory classes (e.g., 6 classes). In this study, instead of screening GMM models 
based on fit measures, we directly evaluate formulated prediction targets in the prediction 
framework focusing on prediction by relevant baseline measures. A wide array of GMM-
based prediction targets can be evaluated in terms of prediction accuracy, which is in line 
with how models are evaluated and selected in supervised learning problems. What is unique 
about our approach is that the goal is to select prediction targets, not to select predictors.
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4.1 Prediction by Antecedent Validators
As a way of validating prediction targets with the emphasis in clinical relevance, we will 
evaluate their relationship with other relevant measures. In particular, given the intended 
purpose of trajectory types as outcomes, we will focus on assessing the quality of prediction 
by relevant baseline variables. The idea is that a good prediction target should be well 
predicted by demographically and clinically relevant baseline characteristics, known as 
antecedent validators.
In line with LAMS, we will focus on a simple binary target (low vs. elevated risk) defined in 
(3.15). With this simplified classification structure, a prediction model with a binary 
outcome Li can be expressed as
(4.1)
where πLiPr(Li = 1|Wi) denotes the probability of subject i belonging to the low risk type 
varying as a function of a vector of baseline covariates Wi. The relationship between the risk 
status L and covariates is captured by a vector of logit coefficients γ1. The baseline 
covariates included here are basic demographic characteristics (sex, age, health insurance as 
proxy for family SES, smoking status) and clinically relevant measures (depression 
measured by CDRS-R, bipolar diagnosis, baseline PGBI-10M). In our LAMS application, 
the covariates included in GMM (Xi) and the covariates used in the validation process (Wi) 
overlap, but are not identical. The baseline bipolar diagnosis, which is considered the most 
clinically relevant antecedent validator, was not used in formation of trajectory classes using 
GMM, but used in the validation step. We consistently used this fixed set of covariates as 
predictors during the validation process.
Based on (4.1), the predicted risk status of individual i is defined as
(4.2)
4.2 Evaluation of Prediction Quality
Using the prediction model in (4.1), we evaluate the quality of prediction on the basis of 
common measures of classification performance. They are sensitivity (S), specificity (P) and 
accuracy (A) defined as
(4.3)
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where true positives (TP) are individuals who belongs to the low risk group (Li = 1) and 
correctly classified as low risk by the prediction model (L̂i(Wi) = 1), true negatives (TN) are 
those who are not in the low risk group (Li = 0) and correctly predicted as not belonging to 
the low risk group (L̂i(Wi) = 0), false positives (FP) are those who are not in the low risk 
group (Li = 0) and incorrectly predicted as low risk (L̂i(Wi) = 1), and false negatives (FN) 
are individuals who belongs to the low risk group (Li = 1) and incorrectly classified as not 
belonging to the low risk group by the prediction model (L̂i(Wi) = 0).
In our validation framework using antecedent validators, evaluating the prediction 
performance itself is already a process of internal validation. This process can be enhanced 
by taking into account variability in prediction quality across different samples. Paying 
much attention to the prediction capability of learning methods on new data is a signature 
feature of supervised learning. However, comparable independent data sets are often rare as 
is the case in LAMS. Given that, internally examining the prediction performance across 
different portions of the data at hand has been an important component in supervised 
learning. For this purpose, a simple, but effective, validation technique known as K-fold 
cross-validation is widely used [23, 24, 39, 40].
4.2.1 K-Fold Cross-Validation—In this method, we randomly divide the total sample 
into K equal size subsamples (k = 1, 2, …, K). Of the K subsamples, we set aside one 
subsample (kth fold) to be used as a validation sample. With the rest of the subsamples 
(training data), we build a prediction model. The validation sample (kth fold) is then used to 
estimate the expected prediction quality when the model is applied to a data set that is not 
used to formulate the prediction model. This process is repeated K times and then the results 
are averaged over K results. Specifically, the three measures of prediction performance, 
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where Sk, Pk and Ak are sensitivity, specificity and accuracy in the kth fold.
We will also use another popular way of model selection based on the one-standard-error 
rule, where we select the most parsimonious model with CV values that are within one 
standard error range of those of the best performing model [23–24]. The standard errors of 




The calculation of CVS, CVP and CVA and their associated standard errors are 
straightforward when the class membership has one version as in (3.15). Alternatively, to 
capture the uncertainty in classification, one could also derive CVS, CVP and CVA based on 
multiple independent pseudoclass draws as in (3.16). That is, for each iteration of 
pseudoclass draw (say the rth iteration), we first obtain  by drawing a random sample 
from the binomial distribution with probability equal to the posterior probability piJ of 
belonging to the low risk class. Then, based on the prediction model in (4.1), 
and  are calculated from each rth pseudoclass draw. Based on the pseudoclass theory, 
CVS, CVP and CVA can be estimated by averaging the estimate of each model validation 
index over multiple independent pseudoclass draws. That is,
(4.12)
(4.13)
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where r = 1, 2, …, R, and the associated standard error is estimated by the squared root of 




where , and  correspond to the calculation of (4.9)–(4.11) for the rth 
pseudoclass draw.
5 Application to LAMS
In the proposed GMM approach, prediction targets are first generated by categorizing 
individuals based on their posterior class probabilities estimated in each GMM model as 
described in (3.15) and (3.16). In the completely separate next step, we validate formulated 
prediction targets in the prediction framework in (4.1). We included basic demographic 
characteristics (sex, age, smoking status, health insurance as proxy for family SES) and 
clinically relevant measures (bipolar diagnosis, depression measured by CDRS-R, baseline 
PGBI-10M) as antecedent validators. Based on these predictors, the quality of prediction 
was assessed in terms of sensitivity and specificity. In this validation step, we used 10-fold 
cross-validation as another enhancement of internal validation, taking into account potential 
variation in prediction quality across different samples.
Before examining the prediction quality using GMM-based prediction targets, we examined 
the prediction quality when prediction targets are generated using observed PGBI-10M at 
each assessment with a fixed clinical threshold, which is a more conventional method of 
classification. We classified individuals as low and elevated risk using the threshold of 12, 
which has been proposed in previous studies [25–27]. The resulting four prediction targets 
(low vs. elevated risk at 6, 12, 18, and 24 month) were evaluated in the same method used to 
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evaluate GMM-based prediction targets. Table 2 shows the prediction quality when 
prediction targets are formulated using this conventional method. The level of sensitivity is 
high for all four targets, although the level of specificity is very low especially when 
predicting targets farther away from the baseline.
In the proposed approach, we first conduct GMM to extract heterogeneous trajectory classes. 
Based on model specifications in (3.1) to (3.10), 36 GMM models with two or more classes 
reached normal convergence (20 without, 16 with covariates), which are summarized in 
Table 3. Based on the simple binary classification structure described in (3.15), 36 binary 
prediction targets were generated based on 36 GMM models. In this study, we monitored 
BIC and BLRT as a way of assessing the model fit. However, instead of screening GMM 
models based on the model fit, we directly evaluate formulated prediction targets in the 
prediction framework.
We focused on a simple classification setting, where separating out a considerable 
proportion of children who would maintain non-problematic levels of manic symptoms is of 
great clinical importance. All candidate GMM models consistently exhibited a trajectory 
class that starts with the estimated PGBI-10M of around 12 or lower and then gradually 
decreases. From the clinical perspective, this bottom trajectory class is clearly the least 
problematic. This interpretation is also supported by a previously suggested clinical 
threshold that sets PGBI-10M ≥ 12 as elevated in manic symptoms [25–27]. However, in 
models with no random effects with seven or more classes, the low risk trajectory split into 
smaller subclasses, resulting in 2–3 classes that could be potentially categorized as low risk. 
In these models, we categorized only the class with the lowest mean trajectory as low risk. 
In comparison to other models, these models will inform us how the prediction quality varies 
depending on how conservatively individuals are classified as low risk. Some examples of 
GMM results are shown in Figure 1, where the solid line at the bottom in each model is the 
trajectory class we categorize as low risk. The rest of the classes are combined and 
categorized as elevated risk.
Once we designate a low risk trajectory class, prediction targets can be generated by 
classifying each individual based on his or her posterior class probability of belonging to 
that low risk trajectory class, as described in (3.15) and (3.16). As this classification happens 
under each GMM model, some individuals, in particular those in the grey zone, may be 
classified as low risk under one model, but not under another model. Examining differences 
in classification for these cases may lead to better understanding of which prediction target 
is more aligned with our clinical intention, and therefore lead to a better informed choice.
Table 4 shows an example of potential disagreement in classification across different GMM 
models. In this example, 5- and 6-class random intercept models with covariates (XC6i and 
XC5i) are compared. In terms of their posterior probabilities of belonging to the low risk 
class (p̂iJ), the two models are highly correlated (r = 0.997). Based on the classification in 
(3.15), 15 individuals (2.2%) out of 682 were classified differently between the two models. 
We examined the observed data of these 15 cases based on 1) whether PGBI-10M ≥ 12 at 
any point and 2) whether the baseline CDRS-R (mean=34.73, SD=10.73) is above the mean. 
Cases 1 to 11 are more likely to be categorized as elevated risk based on XC6i and as low 
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risk based on XC5i. Cases 1–3 have PGBI-10M ≥ 12 only once and the deviation is not 
serious. However, their baseline depression level is considerably higher than average. Cases 
4–8 have PGBI-10M ≥ 12 only once, although the deviation is quite large. Given this 
observation, a safe choice would be to classify these cases (1–8) as elevated risk. Cases 9–11 
are more questionable, especially with missing data, which is reflected in the estimated class 
probabilities close to 0.5 in both models. Cases 12 to 15 are more likely to be categorized as 
low risk based on XC6i, which seems reasonable, although 13 and 15 are somewhat 
questionable given moderately high PGBI-10M scores and missing assessments. Overall, 
XC6i tends to classify uncertain cases as elevated risk, whereas XC5i as low risk. At the 
same time, the agreement between the two models is very high, assuring the possibility of 
stable classification.
In the proposed approach, prediction targets are generated by categorizing patients based on 
their estimated posterior class probabilities. In the completely separate next step, we validate 
formulated prediction targets in the prediction framework as described in (4.1). We first 
evaluated GMM-based prediction targets without taking into account uncertainties in 
classification as defined in (3.15). Figure 2 shows the assessed prediction quality based on 
this approach. As sensitivity and specificity are equally important in the LAMS context, we 
intend to select GMM-based prediction targets that not only lead to the highest overall 
accuracy, but also the highest sensitivity and specificity. We also intend to improve 
prediction accuracy by using GMM-based prediction targets instead of using observed 
measures (see Table 2). Given these considerations, we used 0.7 as the lower limit for the 
sensitivity and specificity estimates of the GMM-based prediction targets. We screened all 
candidate targets based on the rule that CVS −SES ≥ 0.7 and that CVP − SEP ≥ 0.7, 
considering possible variations in prediction quality. Among 36 GMM models considered, 
15 models that satisfied this rule are shown in Figure 2. The best sensitivity was achieved 
using the prediction target based on XC5i (CVS = 0.83), and the best specificity based on 
XC6i (CVP = 0.90). The next best prediction targets are based on random intercept models 
without covariates with 5–7 classes. The quality of prediction based on these models is close 
to that based on XC6i and XC5i.
We repeated our cross-validation taking into account uncertainties in classification. We used 
pseudoclass draws based on the posterior class probability of belonging to the low risk 
trajectory class (p̂iJ), as defined in (3.16), which basically creates multiple versions of 
prediction target based on each GMM model. Using each version of the target (i.e., each 
pseudoclass draw), the quality of prediction can be assessed, and then the results are 
averaged across multiple versions. We used 20 pseudoclass draws. We again screened all 
candidate targets based on the rule that CVS − SES ≥ 0.7 and that CVP − SEP ≥ 0.7. Figure 3 
shows the quality of prediction when uncertainties in classification is taken into account. 
Among 36 GMM models considered, 10 models satisfied the rule this time. Overall, the CV 
results show somewhat lower sensitivity and specificity compared to when uncertainties are 
not taken into account (Figure 2). However, the main story remains the same. The best 
sensitivity was achieved using the prediction target based on XC5i (CVS = 0.77), and the 
best specificity based on XC6i (CVP = 0.87). The next best prediction targets are based on 
random intercept models without covariates with 5–7 classes. The quality of prediction 
based on these models is again quite close to that based on XC6i and XC5i.
Jo et al. Page 15













Table 5 provides some details of the results shown in Figure 3 that take into account 
uncertainties in classification. The two best performing prediction targets based on XC6i and 
XC5i are basically tied in terms of prediction quality, although XC6i is a better choice if we 
prefer classifying individuals somewhat more conservatively. As discussed with Table 4, a 
more informed choice can be made by carefully examining individuals who are differently 
classified by different GMM models. If selecting a more parsimonious model is of interest, 
we can also apply the one-standard-error rule, where we pick the most parsimonious model 
with CV values that are within one standard error range of those of the best performing 
model. For sensitivity, the minimum in the model XC5i is 0.737, and therefore most models 
with fewer parameters in Table 4 are comparable to XC5i. For specificity, the minimum in 
XC6i is 0.855, and therefore four simpler models (XC5i, C6i, C7i, C5i) are comparable to 
XC6i. Together, five best performing models are comparable in terms of prediction quality, 
and C5i would be the most parsimonious choice with only 25 parameters. The five best 
performing models consistently categorized 39–40% of individuals as low risk. Using 
information on model fit will considerably narrow the selection, although it may 
prematurely exclude potentially useful models. Among the five best performing models, 
XC6i and C7i were selected by BLRT, C6i was selected by BIC, but XC5i and C5i were not 
selected either by BLRT or by BIC.
6 Conclusions
GMM has been increasingly used in various research fields for the purpose of meaningful 
interpretation of longitudinal heterogeneity in the target population and inference about how 
these trajectory classes are related to other variables. Expanding such common use of GMM, 
this study showed that GMM can also serve as a useful tool in the context of individual level 
prediction. In particular, we focused on a specific utility of GMM as a way of constructing 
reliable and valid prediction targets. In the proposed GMM approach, prediction targets are 
first generated by categorizing individuals based on their posterior class probabilities 
estimated in each GMM model. In the completely separate next step, formulated prediction 
targets are validated in terms of how well they are predicted by relevant baseline covariates 
(antecendent validators). In this approach, a large array of prediction targets generated by 
GMM (unsupervised learning) are validated in the prediction framework (supervised 
learning).
A small fixed set of antecedent validators was used in the proposed approach to swiftly 
validate GMM-based prediction targets and to narrow the choice among them. In our LAMS 
application, it turned out that the level of prediction accuracy based on this limited selection 
of variables is quite high (both sensitivity and specificity over 0.75) even after taking into 
account uncertainties in classification. We find the results quite promising as our validation 
process can be considered a precursor to developing prognostic models fully considering all 
possible baseline predictors. For this next step of developing prognostic models, a large 
number of baseline covariates, including the ones we used as antecedent validators, can be 
considered as potential predictors. The LAMS study indeed collected rich data in multiple 
domains, providing a valuable opportunity to develop prognostic models with a practical 
level of accuracy. We leave this next step, which naturally involves feature selection, as a 
topic for future investigation.
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Whether covariates should be included in extracting trajectory classes is a debatable issue as 
it may help better classify individuals, but may also lead to misspecified models. Further, it 
is not clear whether we should use covariates redundantly, both as predictors in GMM and as 
predictors in the validation step. Neither seemed to be an issue in our LAMS application, 
where prediction targets formulated based on both GMM with and without covariates (XC6i, 
XC5i, C6i, C7i, C5i) performed comparably well in the validation process. These GMM 
models are also highly correlated (r > 0.98) in terms of the posterior class probability of 
belonging to the low risk trajectory class (p̂iJ), which leaves little room for possible impacts 
of model misspecification involving covariates. In fact, both the GMM and the validation 
process can utilize various types of auxiliary information, not only from the baseline, but 
also from concurrent and distal measures. Further investigation, both theoretical and 
empirical, seems necessary as there is little research in this regard in the context of 
individual level prediction.
To focus on demonstrating our new approach of using GMM, we limited the range of 
models to be examined. We used a simple quadratic growth specification with restricted 
variance structures, although various alternative model specifications are possible. For 
example, our investigation did not include models with higher order polynomial growth 
specifications or class-varying variances. Considering various model specifications will lead 
to a much wider pool of GMM models. According to our investigation with the LAMS data, 
once prediction targets are formulated based on GMM, it seems feasible to process a large 
number of them in the validation process. However, having numerous candidate models can 
still overwhelm the model fitting process, which calls for some guiding principles. Future 
research is warranted to examine the benefits and limitations of different GMM model 
specifications under various application settings.
The proposed method of utilizing and evaluating GMM solutions may take several different 
directions for further development and refinement. In the LAMS application, we constructed 
prediction targets with the purpose of separating out children who would remain non-
problematic over the two-year course. However, prediction targets can be formulated in 
many different ways depending on the specific purpose of classification. For example, our 
next interest is in identifying children who would develop the most problematic trajectory 
type. The best GMM models in the current application may or may not turn out to be the 
best with this shifted target. Another issue that deserves further attention is how to best 
utilize model-based classification and fixed thresholds. In this study, we used model-based 
classification, where we categorize the class with the lowest mean trajectory as low risk and 
the rest as elevated risk. This approach allows the level of outcome in the low risk category 
to vary across different GMM models, allowing us to observe how the prediction quality 
varies depending on how conservatively individuals are classified as low risk. An alternative 
way would be to use fixed thresholds (e.g., estimated PGBI-10M < 12 in LAMS), relying 
less on classification provided by GMM. In this method, the external thresholds can be 
directly applied to estimated individual trajectories, and therefore prediction targets can be 
formulated not only using multi-class, but also using single-class trajectory solutions. 
Further research is needed to examine similarities and differences between these alternative 
methods in various situations.
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Examples of candidate GMM solutions
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Quality of prediction when uncertainties in classification are not taken into account.
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Quality of prediction when uncertainties in classification are taken into account using 
pseudoclass draws.
Jo et al. Page 23


























































































































































































































































Jo et al. Page 25
Table 2
Average sensitivity (CVS) and specificity (CVP) from 10-fold cross-validation in prediction of low risk status 
defined based on a single observed outcome and a fixed threshold (Listwise deletion has been applied. CVS ± 
SES and CVP ± SEP are shown in parentheses).
Observed Outcome %Low Risk Sensitivity Specificity
PGBI-10M 6m < 12 58.2 0.791 (0.764, 0.818) 0.602 (0.571, 0.633)
PGBI-10M 12m < 12 68.3 0.894 (0.879, 0.908) 0.401 (0.341, 0.461)
PGBI-10M 18m < 12 71.0 0.882 (0.860, 0.905) 0.360 (0.324, 0.395)
PGBI-10M 24m < 12 73.9 0.914 (0.895, 0.933) 0.213 (0.173, 0.252)
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Table 3
GMM Models Used for Classification Based on Longitudinal PGBI-10M
Label Model Description # Par
C2is 2-class, random intercept & slope 15
C3is 3-class, random intercept & slope 19
C4is† 4-class, random intercept & slope 23
C5is* 5-class, random intercept & slope 27
C2i 2-class, random intercept 13
C3i 3-class, random intercept 17
C4i 4-class, random intercept 21
C5i 5-class, random intercept 25
C6i† 6-class, random intercept 29
C7i* 7-class, random intercept 33
C2 2-class, no random effect 12
C3 3-class, no random effect 16
C4 4-class, no random effect 20
C5 5-class, no random effect 24
C6† 6-class, no random effect 28
C7 7-class, no random effect 32
C8 8-class, no random effect 36
C9* 9-class, no random effect 40
C10 10-class, no random effect 44
C11 11-class, no random effect 48
XC2is†* 2-class with covariates, random int & slope 31
XC3is 3-class with covariates, random int & slope 39
XC4is 4-class with covariates, random int & slope 47
XC5is 5-class with covariates, random int & slope 55
XC2i 2-class with covariates, random intercept 29
XC3i† 3-class with covariates, random intercept 37
XC4i 4-class with covariates, random intercept 45
XC5i 5-class with covariates, random intercept 53
XC6i* 6-class with covariates, random intercept 61
XC2 2-class with covariates, no random effect 28
XC3 3-class with covariates, no random effect 36
XC4† 4-class with covariates, no random effect 44
XC5* 5-class with covariates, no random effect 52
XC6 6-class with covariates, no random effect 60
XC7 7-class with covariates, no random effect 68
XC8 8-class with covariates, no random effect 76
#
Par is the number of parameters;
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†
indicates a model selected by BIC and
*
by BLRT within each type of random effect structure Σζ with and without covariates
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